Citi raises target for Siemens Healthineers stock from EUR 46 to EUR 47
Published on 10/14/2026 at 13:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget and outlook shift
- Citi set a EUR 47 target and retained its Buy rating on October 13, 2026.
- Fiscal 2026 revenue growth guidance moved to 3.50-4.00 percent after the July 31, 2026 update.
- Siemens Healthineers stock trades at EUR 40.08 at 1:43 p.m. CEST at Lang & Schwarz on October 14, 2026, 0.40 percent above the Xetra close of October 13, 2026.
Siemens Healthineers stock (ISIN DE000SHL1006) was trading at EUR 40.08 at Lang & Schwarz on October 14, 2026 at 1:43 p.m. CEST, 0.40 percent above the Xetra close of October 13, 2026 at EUR 39.92. The immediate company-specific signal is Citi's target increase from EUR 46 to EUR 47, while the bank retained its Buy rating on October 13, 2026, according to Markets Insider.
Target moves to EUR 47
Citi's revised target places the stock 17.29 percent above the Lang & Schwarz price when compared in euros. That calculation uses EUR 47.00 and EUR 40.08, not the separate Xetra reference used for the daily change.
The rating update arrives ahead of Siemens Healthineers' fiscal fourth-quarter results. The higher target contrasts with a more cautious operating outlook, making the November report important for testing whether earnings execution can support the valuation.
What changed in the outlook?
In its fiscal 2026 third-quarter call dated July 31, 2026, Siemens Healthineers lowered its comparable revenue growth outlook from 4.50-5.00 percent to 3.50-4.00 percent. At the same time, it raised adjusted earnings per share guidance to EUR 2.35-2.45, with the increase attributed to tariff refunds, according to Yahoo Finance.
That mix matters for investors: the revenue range was cut by 1.00 to 1.50 percentage points, while the adjusted earnings per share range rose by EUR 0.15. The transcript also identified Diagnostics weakness in China as a central reason for the lower revenue outlook.
Chronology carries three signals
On October 5, 2026, Siemens Healthineers disclosed that it had bought back 49,987 shares between September 28 and October 2, 2026, according to EQS News.
On July 31, 2026, the company reported an equipment book-to-bill ratio of 1.27 for the fiscal third quarter. On October 13, 2026, Citi then lifted its target from EUR 46 to EUR 47, creating a clear sequence from operating demand to external valuation.
Next dates and stock context
Siemens Healthineers lists fiscal fourth-quarter results and an analyst call for November 5, 2026, followed by a US roadshow on November 6, 2026, on its Investor Relations page. The stock's market capitalization is EUR 44.9 billion as of October 14, 2026, while its 52-week range is EUR 32.81 to EUR 49.71.
At Lang & Schwarz, Siemens Healthineers was trading at EUR 40.08 on October 14, 2026 at 1:43 p.m. CEST, plus 0.40 percent versus the Xetra close of October 13, 2026 at EUR 39.92. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Siemens Healthineers stock facts
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- Ticker: SHL
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 14, 2026, 1:43 p.m. CEST): EUR 40.08
- Change versus Xetra close: plus 0.40 percent
- Xetra close (October 13, 2026): EUR 39.92
- Market capitalization: EUR 44.9 billion (as of October 14, 2026)
- 52-week range: EUR 32.81-EUR 49.71 (as of October 14, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: November 5, 2026
Market context: Market report DAX.
